INTRINSIC SYMPATHOMIMETIC ACTIVITY - PHYSIOLOGICAL REALITY OR MARKETING PHENOMENON

被引:11
作者
BLACK, CD [1 ]
MANN, HJ [1 ]
机构
[1] UNIV MINNESOTA, MINNEAPOLIS, MN 55455 USA
来源
DRUG INTELLIGENCE & CLINICAL PHARMACY | 1984年 / 18卷 / 7-8期
关键词
D O I
10.1177/106002808401800701
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:554 / 559
页数:6
相关论文
共 49 条
[1]  
AELLIG WH, 1977, ACTA MED SCAND, P71
[2]   CLINICAL-PHARMACOLOGY OF PINDOLOL [J].
AELLIG, WH .
AMERICAN HEART JOURNAL, 1982, 104 (02) :346-356
[3]   BETA-ADRENOCEPTOR BLOCKING ACTIVITY AND DURATION OF ACTION OF PINDOLOL AND PROPRANOLOL IN HEALTHY VOLUNTEERS [J].
AELLIG, WH .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (02) :251-257
[4]   A STUDY OF THE ADRENOTROPIC RECEPTORS [J].
AHLQUIST, RP .
AMERICAN JOURNAL OF PHYSIOLOGY, 1948, 153 (03) :586-600
[5]  
Barger G, 1910, J PHYSIOL-LONDON, V41, P19
[6]  
BENSON MK, 1977, POSTGRAD MED J, V53, P143
[7]   ADVERSE EFFECTS OF BETA-ADRENERGIC-RECEPTOR BLOCKING-DRUGS ON RESPIRATORY-FUNCTION [J].
BEUMER, HM .
DRUGS, 1974, 7 (1-2) :130-138
[8]  
BEUMER HM, 1972, INDIAN HEART J S1, V23, P226
[9]  
BRYAN LJ, 1981, J PHARMACOL EXP THER, V216, P395
[10]   MEASUREMENT OF PARTIAL AGONIST ACTIVITY OF PINDOLOL [J].
CARRUTHERS, SG ;
TWUMBARIMA, Y .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (05) :581-586